2QP-41799-06039
2 vaccinations
1 coded response
17 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 852 / AZ
- Registered
- 2022-12-19
- Relationship
- Child or adolescent in my care
- Guardian
- 3J2-14138-63299
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-12-14
Dose 1 — Pfizer-BioNTech
-
2022-12-19
Registered in v-safe
-
2022-12-19
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
-
2022-12-20
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-12-21
- 2022-12-28
-
2023-01-03
Dose 2 — Pfizer-BioNTech
- 2023-01-04
- 2023-01-05
- 2023-01-06
- 2023-01-07
- 2023-01-08
- 2023-01-09
- 2023-01-12
- 2023-01-17
- 2023-01-24
-
2023-01-31
Survey response — day 28, dose 2, under 3MedDRA: Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
- 2023-02-07
- 2023-02-14
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-12-14 | Pfizer-BioNTech | No |
| 2 | 2023-01-03 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release